论文部分内容阅读
骨髓增生异常综合征(MDS)是一组以造血细胞系增殖与成熟异常为特征的异质性疾病。根据FAB小组意见,分为RA、RAS、CMML、RAEB及RAEB-t5种亚型。已有报告指出,MDS的预后与临床类型及细胞遗传学等因素有关,但对其骨髓细胞表型及体外培养生长情况与临床的关系尚无公开报道,本文就此对35例初诊的MDS患者进行了研究。35例中
Myelodysplastic syndrome (MDS) is a group of heterogeneous diseases characterized by abnormal proliferation and maturation of hematopoietic cell lines. According to the FAB group’s opinion, it is divided into five subtypes of RA, RAS, CMML, RAEB and RAEB-t. It has been reported that the prognosis of MDS and clinical types and cytogenetics and other factors, but its bone marrow phenotype and in vitro growth and clinical status of the relationship has not been publicly reported, this article on the 35 cases of newly diagnosed MDS patients Study. 35 cases